These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2522806)
21. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer. Lamm DL; DeHaven JI; Shriver J; Sarosdy MF J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691 [TBL] [Abstract][Full Text] [Related]
22. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients. Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445 [TBL] [Abstract][Full Text] [Related]
23. Cytological changes induced by intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Takashi M; Schenck U; Koshikawa T; Nakashima N; Ohshima S Urol Int; 2000; 64(2):74-81. PubMed ID: 10810268 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of lymphocyte subpopulations of the bladder following endovesical immunotherapy using BCG]. Peuchmaur M; Vieillefond A; Benoit G; Jardin A Ann Urol (Paris); 1989; 23(3):246-50. PubMed ID: 2742354 [TBL] [Abstract][Full Text] [Related]
25. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder. Huffman JL; Fradet Y; Cordon-Cardo C; Herr HW; Pinsky CM; Oettgen HF; Old LJ; Whitmore WF; Melamed MR Cancer Res; 1985 Oct; 45(10):5201-4. PubMed ID: 4027997 [TBL] [Abstract][Full Text] [Related]
26. Intravesical BCG administration in the guinea pig. II. Immunohistochemical characterization of cellular infiltrate after one or two cycles of intravesical BCG. de Jong WH; De Boer EC; Van Der Meijden AP; Steerenberg PA; Debruyne FM Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(3):159-67. PubMed ID: 1685277 [TBL] [Abstract][Full Text] [Related]
27. [The role of lymphocytes and histiocytes as mechanism of action of BCG for bladder cancer]. Kudo S; Suzuki T; Inazumi H Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):303-12. PubMed ID: 8464184 [TBL] [Abstract][Full Text] [Related]
29. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group. Aso Y; Akaza H; Kameyama S; Niijima T Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000 [No Abstract] [Full Text] [Related]
30. Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences. Böhle A; Busemann E; Gerdes J; Ulmer AJ; Flad HD; Jocham D Dev Biol Stand; 1992; 77():199-209. PubMed ID: 1426663 [TBL] [Abstract][Full Text] [Related]
31. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341 [TBL] [Abstract][Full Text] [Related]
35. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)]. Jakse G Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186 [TBL] [Abstract][Full Text] [Related]
36. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor. Steg A; Belas M; Leleu C; Boccon-Gibod L Prog Clin Biol Res; 1989; 303():375-81. PubMed ID: 2780654 [No Abstract] [Full Text] [Related]
37. Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder. Reitsma DJ; Guinan P; Lamm DL; Khanna OP; Brosma SA; DeKernion JB; Williams RD; Sipmson G; Hanna MG Prog Clin Biol Res; 1989; 310():171-85. PubMed ID: 2672014 [No Abstract] [Full Text] [Related]
39. Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations. Mitropoulos D; Deliconstantinos G; Zervas A; Giannopoulos A; Kyriakou G; Dimopoulos C In Vivo; 2000; 14(6):721-4. PubMed ID: 11204488 [TBL] [Abstract][Full Text] [Related]
40. Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group. Akaza H; Hinotsu S; Aso Y; Kakizoe T; Koiso K Cancer; 1995 Jan; 75(2):552-9. PubMed ID: 7812924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]